Lynparza Tablets Approved in EU to Treat Advanced, Platinum-sensitive Ovarian Cancers
News
The European Medicines Agency (EMA) has approved Lynparza (olaparib) tablets as a maintenance therapy for ovarian cancer patient who have relapsed, but have had a complete or partial response to platinum-based chemotherapy, and ... Read more